The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).
 
Giacomo Bregni
No Relationships to Disclose
 
Chiara Senti
No Relationships to Disclose
 
Elena Acedo Reina
No Relationships to Disclose
 
Paraskevas Gkolfakis
No Relationships to Disclose
 
Luigi Moretti
No Relationships to Disclose
 
Ana Veron
No Relationships to Disclose
 
Pieter Demetter
No Relationships to Disclose
 
Gabriel Liberale
No Relationships to Disclose
 
Javier Carrasco
No Relationships to Disclose
 
Karen Paula Geboes
No Relationships to Disclose
 
Yeter Gokburun
No Relationships to Disclose
 
Marc Peeters
Honoraria - Amgen; Bayer; Merck Serono; Roche; Sanofi; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Remedus; Sanofi; SERVIER; Sirtex Medical; TERUMO
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen; Bayer; Ipsen; Novartis; Roche
 
Marc Van Den Eynde
Consulting or Advisory Role - amgen (Inst); Lilly (Inst); Merck KGaA (Inst); SERVIER (Inst)
Research Funding - Merck KGaA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Roche (Inst)
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Philippe Vergauwe
No Relationships to Disclose
 
Marc E. Buyse
No Relationships to Disclose
 
Amélie Deleporte
Travel, Accommodations, Expenses - Amgen; Ipsen
 
Alain Hendlisz
Consulting or Advisory Role - Bayer (Inst); MSD Oncology (Inst); Sirtex Medical (Inst)
Research Funding - Amgen (Inst); Lilly (Inst); Sanofi/Aventis (Inst); Servier/Pfizer (Inst)
 
Francesco Sclafani
Consulting or Advisory Role - Amal Therapeutics; Bayer; Bristol-Myers Squibb; Dragonfly Therapeutics
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly